1,300
Participants
Start Date
November 30, 2022
Primary Completion Date
November 1, 2027
Study Completion Date
November 1, 2027
Drug-Drug Interaction Profile
A profile based on genetic testing that shows information about how the participant's medications they are taking interact with each other.
Drug-Gene Interaction Profile
A profile based on genetic testing that shows information about how the participant's genes interact with/respond to certain medications they are taking.
Standard of Care
The standard treatment and prescribing for the participant's specific type of cancer.
RECRUITING
University of Chicago Medicine, Chicago
University of Chicago
OTHER